SEER vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

SEER

36.9
AI Score
VS
CBIO Wins

CBIO

58.4
AI Score

Investment Advisor Scores

SEER

37score
Recommendation
SELL

CBIO

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SEER CBIO Winner
Revenue 5.89M 1.04M SEER
Net Income -33.74M -48.12M SEER
Net Margin -572.3% -4631.4% SEER
Operating Income -34.10M -51.09M SEER
ROE -14.9% -29.5% SEER
ROA -13.1% -26.3% SEER
Total Assets 256.64M 182.76M SEER
Cash 26.07M 171.59M CBIO
Current Ratio 14.74 9.66 SEER
Free Cash Flow -25.29M -28.56M SEER

Relative Price Performance (Last 90 Days)

SEER 1M: +13.4% · 3M: +35.8% CBIO 1M: -20.5% · 3M: -16.6%

Current Technical Phase

SEER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 68.9 · Price: $2.20

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.1 · Price: $14.26

Fundamentals Snapshot

Metric SEER CBIO
Market Cap — —
Forward P/E -2.2 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.5% 1.0%
Operating Margin -5.4% -14.3%
EPS -1.27 -0.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.